ASPCD Projected Dividend Yield
Acerus Pharmaceuticals Corp ( OTCBB : ASPCD )Acerus Pharmaceuticals is engaged in developing medications for male hypogonadism, female sexual dysfunction, and various respiratory disorders. The Co. holds the development and marketing rights to a bioadhesive intranasal gel drug delivery technology platform and owns a novel dry power drug delivery technology platform and is actively pursuing the development and application of these technologies to products that are currently in Phase II and Phase III clinical testing. These drug delivery platforms are: (a) a bioadhesive intranasal gel and (b) a unit dose dry powder inhaler/nasal dispersion system. 21 YEAR PERFORMANCE RESULTS |
ASPCD Dividend History Detail ASPCD Dividend News ASPCD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |